Eagle Pharmaceuticals Inc. (EGRX) announced Wednesday afternoon that it has received a Complete Response Letter from the FDA for its New Drug Application for RYANODEX for the treatment of exertional heat stroke, in conjunction with external cooling methods.
from RTT - Before the Bell http://ift.tt/2uAHUet
via IFTTT
No comments:
Post a Comment